AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Fall Risk in Adults Over 65: The Relevance of Morphological and Functional Lower Limb Asymmetries.

Recruitingn/aAges 65 Years - anyAllI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Falls among older adults represent a major public health burden. Approximately 30% of individuals aged 65 and older experience at least one fall each year. These events can lead not only to increased anxiety, depression, and reduced quality of life but also to serious injuries or even death. Key risk factors include muscle weakness, gait disturbances, and balance impairments. Lower limb asymmetry-referring to differences in strength, flexibility, composition, or functional capacity between the two legs-has emerged as a potentially important yet underexplored contributor to fall risk in the elderly population. While asymmetry is frequently studied in the context of sports and physical performance, where it may affect both injury risk and athletic outcomes, its implications for balance and mobility in older adults remain insufficiently investigated. This study aims to examine the relations

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Male or female, of any ethnicity. * Age โ‰ฅ 65 years. * Cognitively intact. * Independent ambulation. * Signed and accepted informed consent to participate in all procedures required for the study. Exclusion Criteria: * Previous surgical treatments for orthopedic conditions performed within the six months prior to study inclusion. * Severe cardiac, pulmonary, or musculoskeletal disorders that may influence the assessment outcomes. * Comorbidities associated with increased fall risk, such as Parkinson's disease or stroke. * Body Mass Index โ‰ฅ 30.0. * Use of medications that affect motor coordination, balance, or bone and muscle metabolism. * Active oncological disease.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
IRCCS Ospedale Galeazzi-Sant'Ambrogio
Milan, Italy
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy